Publications of Inaam A. Nakchbandi

Wirth, F.; Zoeller, C.; Lubosch, A.; Schroeder-Braunstein, J.; Wabnitz, G.; Nakchbandi, I. A.: Insights into the metastatic bone marrow niche gained from fibronectin and ß1 integrin transgenic mice. Neoplasia 58, 101058 (2024)

Ghura, H.; Keimer, M.; von Au, A.; Hackl, N.; Klemis, V.; Nakchbandi, I. A.: Inhibition of fibronectin accumulation suppresses tumor growth. Neoplasia 23 (9), pp. 837 - 850 (2021)

Klapproth, S.; Richter, K.; Tuerk, C.; Bock, T.; Bromberger, T.; Dominik, J.; Huck, K.; Pfaller, K.; Hess, M. W.; Reichel, C. A. et al.; Krueger, M.; Nakchbandi, I. A.; Moser, M.: Low kindlin-3 levels in osteoclasts of kindlin-3 hypomorphic mice result in osteopetrosis due to leaky sealing zones. Journal of Cell Science 134 (22), jcs259040 (2021)

Wirth, F.; Huck, K.; Lubosch, A.; Zoeller, C.; Ghura, H.; Porubsky, S.; Nakchbandi, I. A.: Cdc42 in osterix-expressing cells alters osteoblast behavior and myeloid lineage commitment. Bone 153, 116150 (2021)

Rossnagl, S.; Ghura, H.; Groth, C.; Altrock, E.; Jakob, F.; Schott, S.; Wimberger, P.; Link, T.; Kuhlmann, J. D.; Stenzl, A. et al.; Hennenlotter, J.; Todenhoefer, T.; Rojewski, M.; Bieback, K.; Nakchbandi, I.: A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow. Cancer Research 78 (1), pp. 129 - 142 (2018)

Sens, C.; Altrock, E.; Rau, K.; Klemis, V.; von Au, A.; Pettera, S.; Uebel, S.; Damm, T.; Tiwari, S.; Moser, M. et al.; Nakchbandi, I. A.: An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through alpha 4 beta 1 Integrin. Journal of Bone and Mineral Research 32 (1), pp. 70 - 81 (2017)

Sens, C.; Huck, K.; Pettera, S.; Uebel, S.; Wabnitz, G.; Moser, M.; Nakchbandi, I.: Fibronectins containing extradomain A or B enhance osteoblast differentiation via distinct integrins. Journal of Biological Chemistry 292 (19), pp. 7745 - 7760 (2017)

Rossnagl, S.; Altrock, E.; Sens, C.; Kraft, S.; Rau, K.; Milsom, M. D.; Giese, T.; Samstag, Y.; Nakchbandi, I. A.: EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer. PLoS Biology 14 (9), e1002562 (2016)

Kraft, S.; Klemis, V.; Sens, C.; Lenhard, T.; Jacobi, C.; Samstag, Y.; Wabnitz, G.; Kirschfink, M.; Wallich, R.; Hänsch, G. M. et al.; Nakchbandi, I. A.: Identification and characterization of a unique role for EDB fibronectin in phagocytosis. JOURNAL OF MOLECULAR MEDICINE-JMM 94 (5), pp. 567 - 581 (2016)

Altrock, E.; Sens, C.; Wuerfel, C.; Vasel, M.; Kawelke, N.; Dooley, S.; Sottile, J.; Nakchbandi, I.: Erratum to “Inhibition of fibronectin deposition improves experimental liver fibrosis” [J Hepatol 2015;62:625–633]. JOURNAL OF HEPATOLOGY 62 (6), pp. 1455 - 1456 (2015)

Altrock, E.; Sens, C.; Wuerfel, C.; Vasel, M.; Kawelke, N.; Dooley, S.; Sottile, J.; Nakchbandi, I.: Inhibition of fibronectin deposition improves experimental liver fibrosis. Journal of Hepatology 62 (3), pp. 625 - 633 (2015)

Vasel, M.; Rutz, R.; Bersch, C.; Feick, P.; Singer, M. V.; Kirschfink, M.; Nakchbandi, I. A.: Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C. CLINICAL IMMUNOLOGY 150 (2), pp. 149 - 156 (2014)

Nakchbandi, I.: Osteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications. WORLD JOURNAL OF GASTROENTEROLOGY 20 (28), pp. 9427 - 9438 (2014)

Riplinger, S. M.; Wabnitz, G. H.; Kirchgessner, H.; Jahraus, B.; Lasitschka, F.; Schulte, B.; van der Pluijm, G.; van der Horst, G.; Haemmerling, G. J.; Nakchbandi, I. et al.; Samstag, Y.: Metastasis of prostate cancer and melanoma cells in a preclinical in vivo mouse model is enhanced by L-plastin expression and phosphorylation. MOLECULAR CANCER 13, 10 (2014)

Rossnagl, S.; von Au, A.; Vasel, M.; Cecchini, A. G.; Nakchbandi, I. A.: Blood Clot Formation Does Not Affect Metastasis Formation or Tumor Growth in a Murine Model of Breast Cancer. PLOS ONE 9 (4), e94922 (2014)

von Au, A.; Vasel, M.; Kraft, S.; Sens, C.; Hackl, N.; Marx, A.; Stroebel, P.; Hennenlotter, J.; Todenhoefer, T.; Stenzl, A. et al.; Schott, S.; Sinn, H.-P.; Wetterwald, A.; Bermejo, J. L.; Cecchini, M. G.; Nakchbandi, I. A.: Circulating Fibronectin Controls Tumor Growth. NEOPLASIA 15 (8), pp. 925 - 938 (2013)

Wuerfel, C.; Hoffmann, C.; Kawelke, N.; Aszodi, A.; Nakchbandi, I.: Deletion of cdc42 in osteoblast progenitors leads to increased adipocyte differentiation and decreased bone formation. Bone 50 (Suppl. 1), p. S43 - S43 (2012)

Kawelke, N.; Vasel, M.; Sens, C.; von Au, A.; Dooley, S.; Nakchbandi, I. A.: Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-beta. PLoS ONE 6 (11), e28181, pp. [1] - [14] (2011)

Brunner, M.; Millon-Fremillon, A.; Chevalier, G.; Nakchbandi, I. A.; Mosher, D.; Block, M. R.; Albiges-Rizo, C.; Bouvard, D.: Osteoblast mineralization requires beta 1 integrin/ICAP-1-dependent fibronectin deposition. Journal of Cell Biology 194 (2), pp. 307 - 322 (2011)

Schmidt, S.; Nakchbandi, I.; Ruppert, R.; Kawelke, N.; Hess, M. W.; Pfaller, K.; Jurdic, P.; Fässler, R.; Moser, M.: Kindlin-3-mediated signaling from multiple integrin classes is required for osteoclast-mediated bone resorption. Journal of Cell Biology 192 (5), pp. 883 - 897 (2011)